Recent research indicates RV and quercetin, at varying doses, decrease inflammation by impacting SFRP4, a protein involved in obesity, diabetes, and pancreatic inflammation, thus highlighting a connection between obesity-driven inflammation and dysfunctional insulin response. The gene discussed is SFRP4; the disease is obesity disorder.